BioCryst's total assets for Q1 2025 were $480.05M, a decrease of -2.12% from the previous quarter. BCRX total liabilities were $931.97M for the fiscal quarter, a -3.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.